The aim of this work, therefore, was to quantitatively compare the proteomic profiles of skin fibroblasts from patients with Type I, Type II and Type III SMA to identify whether a core molecular response to reduced SMN is conserved across the different types of SMA, and then to highlight detectable molecular differences that exist between SMA type and severity. Here, SMN2 is linked to proximal spinal muscular atrophy.